Stories Tagged as
COVID-19 vaccine
The COVID vaccine rollout is kind of a mess. Again.
by
Nova Safo
Sep 29, 2023
This is the first round of COVID vaccinations relying mostly on the usual health insurance and provider networks as opposed to the government.
How a combination of COVID lawsuits and media coverage keeps misinformation churning
by
Darius Tahir
Jul 14, 2023
Even as the COVID-19 pandemic wanes, litigation — whether about vaccines, masks or a range of other public health policies made during the pandemic — isn’t about to end.
China's zero-COVID whiplash
by
Jennifer Pak
Jan 5, 2023
China has abandoned its sweeping restrictions after nearly three years. Heads are spinning from the speed of the change, and infections are spreading quickly.
What happens once federal funding to fight COVID ends?
Aug 31, 2022
FDA approved updated boosters Wednesday. The feds have helped cover costs of vaccination and testing as well as public awareness drives.
What's the right vaccine strategy to fight against COVID variants?
by
Lily Jamali
Aug 16, 2022
The U.K. is targeting the BA.1 subvariant of omicron while the U.S. is targeting the more recent BA.4 and BA.5 omicron strains.
At this point in the pandemic, will there be a market for the Novavax vaccine?
Jun 8, 2022
The anti-COVID shot passes muster with FDA advisers. It was developed with traditional technology, which might boost trust.
A New Jersey community pharmacy's vaccine rollout, a year later
Mar 1, 2022
This time last year, Bell Pharmacy was doing everything it could to prepare for COVID-19 vaccines ... without knowing when the doses would arrive.
For public good, not for profit.
WHO plan will help ramp up COVID vaccine production in Africa
by
Lily Jamali
Feb 18, 2022
Egypt, Kenya, Nigeria, Senegal, South Africa and Tunisia will have access to mRNA vaccine technology. Is that enough?
COVID-19 vaccine for kids under 5 could be available soon
Feb 2, 2022
As the number of vaccinated people increases, so does movement in the economy.
Investors pressure Moderna to broaden global access to vaccine
by
Lily Jamali
Dec 28, 2021
The company is under scrutiny over vaccine equity. It received considerable U.S. government help in developing its vaccine.